161 related articles for article (PubMed ID: 28503689)
1. Effects of elemene on inhibiting proliferation of vascular smooth muscle cells and promoting reendothelialization at the stent implantation site.
Sun W; Huang Y; Yin T; Wang J; Du R; Qiu J; Zhang Y; Wang Y; Chen J; Wang G
Biomater Sci; 2017 May; 5(6):1144-1155. PubMed ID: 28503689
[TBL] [Abstract][Full Text] [Related]
2. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
[TBL] [Abstract][Full Text] [Related]
3. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
Jaschke B; Milz S; Vogeser M; Michaelis C; Vorpahl M; Schömig A; Kastrati A; Wessely R
FASEB J; 2004 Aug; 18(11):1285-7. PubMed ID: 15180955
[TBL] [Abstract][Full Text] [Related]
4. The Role of Tauroursodeoxycholic Acid on Dedifferentiation of Vascular Smooth Muscle Cells by Modulation of Endoplasmic Reticulum Stress and as an Oral Drug Inhibiting In-Stent Restenosis.
Luo H; Zhou C; Chi J; Pan S; Lin H; Gao F; Ni T; Meng L; Zhang J; Jiang C; Ji Z; Lv H; Guo H
Cardiovasc Drugs Ther; 2019 Feb; 33(1):25-33. PubMed ID: 30663009
[TBL] [Abstract][Full Text] [Related]
5. Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model.
Yang W; Ge J; Liu H; Zhao K; Liu X; Qu X; Li W; Huang Y; Sun A; Zou Y
Cardiovasc Res; 2006 Dec; 72(3):483-93. PubMed ID: 17020754
[TBL] [Abstract][Full Text] [Related]
6. Effect of a novel peptide, WKYMVm- and sirolimus-coated stent on re-endothelialization and anti-restenosis.
Jang EJ; Bae IH; Park DS; Lee SY; Lim KS; Park JK; Shim JW; Sim DS; Jeong MH
J Mater Sci Mater Med; 2015 Oct; 26(10):251. PubMed ID: 26438653
[TBL] [Abstract][Full Text] [Related]
7. Protection of endothelial cells, inhibition of neointimal hyperplasia by β-elemene in an injured artery.
Wu L; Wang G; Tang S; Long G; Yin T
Cardiovasc Drugs Ther; 2011 Jun; 25(3):233-42. PubMed ID: 21607546
[TBL] [Abstract][Full Text] [Related]
8. Effect of stent coating alone on in vitro vascular smooth muscle cell proliferation and apoptosis.
Curcio A; Torella D; Cuda G; Coppola C; Faniello MC; Achille F; Russo VG; Chiariello M; Indolfi C
Am J Physiol Heart Circ Physiol; 2004 Mar; 286(3):H902-8. PubMed ID: 14592937
[TBL] [Abstract][Full Text] [Related]
9. [Tanshinone II A inhibits in vitro cellular proliferation and migration of vascular smooth muscle cell of rabbit].
Zhang HH; Chen YC; Liang L; Zeng Z
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 39(2):188-92. PubMed ID: 18630680
[TBL] [Abstract][Full Text] [Related]
10. [Experimental study on effect of allicin in inhibiting insulin-induced vascular smooth muscle cell proliferation and migration].
Li T; Xia Y
Zhongguo Zhong Yao Za Zhi; 2014 Oct; 39(20):4040-4. PubMed ID: 25751959
[TBL] [Abstract][Full Text] [Related]
11. [Arsenic trioxide eluting stents to prevent restenosis of injured iliac arteries in rabbits].
Yang W; Ge JB; Liu HL; An Y; Liu XB; Tian Y; Qu XF; Li WM; Huang YL
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jan; 34(1):14-8. PubMed ID: 16626542
[TBL] [Abstract][Full Text] [Related]
12. Enhanced sterol response element-binding protein in postintervention restenotic blood vessels plays an important role in vascular smooth muscle proliferation.
Zhou RH; Pesant S; Cohn HI; Eckhart AD
Life Sci; 2008 Jan; 82(3-4):174-81. PubMed ID: 18068195
[TBL] [Abstract][Full Text] [Related]
13. Cyclic strain amplitude dictates the growth response of vascular smooth muscle cells in vitro: role in in-stent restenosis and inhibition with a sirolimus drug-eluting stent.
Colombo A; Guha S; Mackle JN; Cahill PA; Lally C
Biomech Model Mechanobiol; 2013 Aug; 12(4):671-83. PubMed ID: 22961302
[TBL] [Abstract][Full Text] [Related]
14. Effects of curcumin for preventing restenosis in a hypercholesterolemic rabbit iliac artery stent model.
Jang HS; Nam HY; Kim JM; Hahm DH; Nam SH; Kim KL; Joo JR; Suh W; Park JS; Kim DK; Gwon HC
Catheter Cardiovasc Interv; 2009 Nov; 74(6):881-8. PubMed ID: 19496118
[TBL] [Abstract][Full Text] [Related]
15. Basic fibroblast growth factor as a potential stent coating material inducing endothelial cell proliferation.
Kitamura N; Hasebe T; Matsumoto T; Hotta A; Suzuki T; Yamagami T; Terada H
J Atheroscler Thromb; 2014; 21(5):477-85. PubMed ID: 24366328
[TBL] [Abstract][Full Text] [Related]
16. Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.
Yao Y; Hu Z; Ye J; Hu C; Song Q; Da X; Yu Y; Li H; Xu C; Chen Q; Wang QK
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28649088
[TBL] [Abstract][Full Text] [Related]
17. A perlecan-inducing compound significantly inhibits smooth muscle cell function and in-stent intimal hyperplasia: novel insights into the diverse biological effects of perlecan.
Segev A; Nili N; Osherov AB; Qiang B; Wong AJ; Pillarisetti S; Strauss BH
EuroIntervention; 2010 May; 6(1):134-40. PubMed ID: 20542809
[TBL] [Abstract][Full Text] [Related]
18. Anti-Restenotic Roles of Dihydroaustrasulfone Alcohol Involved in Inhibiting PDGF-BB-Stimulated Proliferation and Migration of Vascular Smooth Muscle Cells.
Li PC; Sheu MJ; Ma WF; Pan CH; Sheu JH; Wu CH
Mar Drugs; 2015 May; 13(5):3046-60. PubMed ID: 25988521
[TBL] [Abstract][Full Text] [Related]
19. Local MicroRNA Modulation Using a Novel Anti-miR-21-Eluting Stent Effectively Prevents Experimental In-Stent Restenosis.
Wang D; Deuse T; Stubbendorff M; Chernogubova E; Erben RG; Eken SM; Jin H; Li Y; Busch A; Heeger CH; Behnisch B; Reichenspurner H; Robbins RC; Spin JM; Tsao PS; Schrepfer S; Maegdefessel L
Arterioscler Thromb Vasc Biol; 2015 Sep; 35(9):1945-53. PubMed ID: 26183619
[TBL] [Abstract][Full Text] [Related]
20. A TRPC3 blocker, ethyl-1-(4-(2,3,3-trichloroacrylamide)phenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate (Pyr3), prevents stent-induced arterial remodeling.
Koenig S; Schernthaner M; Maechler H; Kappe CO; Glasnov TN; Hoefler G; Braune M; Wittchow E; Groschner K
J Pharmacol Exp Ther; 2013 Jan; 344(1):33-40. PubMed ID: 23010361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
